(Q38084062)

28 August 2017

Glucocerebrosidase, a new player changing the old rules in Lewy body diseases (English)

1 reference

28 August 2017

Na-Young Yang

1

1 reference

28 August 2017

Yu-Na Lee

2

1 reference

28 August 2017

He-Jin Lee

3

1 reference

28 August 2017

Yoon Suk Kim

4

1 reference

28 August 2017

Seung-Jae Lee

5

1 reference

28 August 2017

1 July 2013

1 reference

28 August 2017

1 reference

28 August 2017

394

1 reference

28 August 2017

7

1 reference

28 August 2017

807-818

1 reference

Small molecules enhance autophagy and reduce toxicity in Huntington's disease models.

28 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

A block of autophagy in lysosomal storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Association of glucocerebrosidase mutations with dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Intravesicular localization and exocytosis of alpha-synuclein and its aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Glucocerebrosidase mutations in subjects with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Critical role of iron in the pathogenesis of the murine gangliosidoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Secondary accumulation of gangliosides in lysosomal storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Parkinsonism among Gaucher disease carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Invited Article: Nervous system pathology in sporadic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Exosomal cell-to-cell transmission of alpha synuclein oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Secondary sphingolipid accumulation in a macrophage model of Gaucher disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Neuropathology provides clues to the pathophysiology of Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Pathogenic lysosomal depletion in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Genetics of Parkinson disease: paradigm shifts and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Proteomic identification of novel proteins associated with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Synucleinopathies: clinical and pathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

The link between the GBA gene and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Protective roles for induction of autophagy in multiple proteinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Lipid rafts mediate the synaptic localization of alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Divergent phenotypes in Gaucher disease implicate the role of modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

Lipid composition of microdomains is altered in a cell model of Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHSZ-2012-0322

21 January 2018

Identifiers

DOI

10.1515/HSZ-2012-0322

1 reference

28 August 2017

1 reference